BiotechTubeBiotechTube
Home/Sagimet Biosciences/Anne Phillips
AP

Anne Phillips

Board Director

Sagimet Biosciences

Roles

Board DirectoratSagimet Biosciences
Non-Executive DirectoratBarinthus Biotherapeutics

Therapeutic Areas

Metabolic DiseaseDermatologyOncology

Sagimet Biosciences Pipeline

DrugIndicationPhase
DenifanstatMetabolic Dysfunction-Associated Steatohepatitis (MASH) with F2/F3 fibrosisPhase 3-ready
Denifanstat (ASC40)Moderate to Severe Acne VulgarisPhase 3
Denifanstat / ResmetiromMASH (implied)Phase 2
TVB-3567AcnePhase 1

Leadership Team at Sagimet Biosciences

DH
David Happel
Chief Executive Officer & Director
EB
Eduardo Bruno Martins
Chief Medical Officer
TC
Thierry Chauche
Chief Financial Officer
MO
Marie O'Farrell
Chief Scientific Officer
GK
George Kemble
Chair of the Board
BS
Beth Seidenberg
Lead Independent Director
View full Sagimet Biosciences profile